This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
MM - 1135
Multiple Myeloma (MM)
Efficacy Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) and Baseline Renal Impairment Treated With at Least 2 Prior Lines of Therapy in the DREAMM-7 Trial